Abstracts extent of generic drug utilisation for the two main drug schemes, the General Medical Services (GMS) scheme and the Drugs Payment (DP) scheme, was measured. Under the GMS scheme, all prescribed drugs are fully reimbursement by the state. Under the DP scheme the patient pays up to €70/month for prescribed drugs and the state pays the remainder. Potential savings from generic substitution for both schemes were investigated. METHODS: The cost and quantity of drugs dispensed in 2001 were analysed using a national primary care prescribing database, which contains information on the brand name, strength, form and cost of prescribed drugs. Drugs are categorised into 4 classes on the database: generic, branded generic, proprietary drug with a generic equivalent, proprietary drug with no generic equivalent. The analysis was performed using JMP and SAS (SAS Institute Inc.). RESULTS: On the GMS scheme 22% of prescription items were dispensed generically, whereas on the DP scheme 12% were dispensed generically. On both the GMS and DP schemes 18% of prescription items were dispensed as a proprietary preparation when a generic equivalent was available. Substitution of the cheapest generic equivalent preparation would result in estimated annual savings of €14.54 million (3.4% of total expenditure) on the GMS scheme and €4.88 million (2.7% of total expenditure) on the DP scheme. CONCLUSIONS:
extent of generic drug utilisation for the two main drug schemes, the General Medical Services (GMS) scheme and the Drugs Payment (DP) scheme, was measured. Under the GMS scheme, all prescribed drugs are fully reimbursement by the state. Under the DP scheme the patient pays up to €70/month for prescribed drugs and the state pays the remainder. Potential savings from generic substitution for both schemes were investigated. METHODS: The cost and quantity of drugs dispensed in 2001 were analysed using a national primary care prescribing database, which contains information on the brand name, strength, form and cost of prescribed drugs. Drugs are categorised into 4 classes on the database: generic, branded generic, proprietary drug with a generic equivalent, proprietary drug with no generic equivalent. The analysis was performed using JMP and SAS (SAS Institute Inc.). RESULTS: On the GMS scheme 22% of prescription items were dispensed generically, whereas on the DP scheme 12% were dispensed generically. On both the GMS and DP schemes 18% of prescription items were dispensed as a proprietary preparation when a generic equivalent was available. Substitution of the cheapest generic equivalent preparation would result in estimated annual savings of €14.54 million (3.4% of total expenditure) on the GMS scheme and €4.88 million (2.7% of total expenditure) on the DP scheme. CONCLUSIONS:
The results highlight the potential cost savings, which could be made by generic substitution, facilitating the most efficient use of the limited drugs budget.
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THE DRUG PRICE REFERENCE INDEX STUDY OF THE PHILIPPINE HEALTH INSURANCE CORPORATION
Valera MR, Roan GM, Dequito AB, Palafox B, Banzon EP, Wong JQ Philippine Health Insurance Corporation, Pasig, Metro Manila, Philippines OBJECTIVES: The objective of this study is to describe the current state of Philippine drug prices across various data sources. METHODS: Retail drug price data was gathered for a list of the 124 pharmacologically active ingredients most commonly reimbursed by PHIC. This list was generated from a systematic sample of 410 claims from a total 305,482 processed claims filed at the National Capital Region office during the calendar year 2000. This sample also served as a source of national drug price data. Other sources of price data included a survey of international drug prices, and a joint Department of Health-Management Sciences for Health drug price survey from 64 points of sale throughout the country. RESULTS: Data gathered from local sources displayed a large degree of variation. From the PHIC processed claims sample, the average relative price difference between identical drug preparations was 382.7% (SD ± 1080.3). Similarly, price data from the joint DOH-MSH survey displayed an average relative price difference of 247.4% (SD ± 538.4). Comparison of local to international price data showed that Philippine prices for certain drug products may be 10-15 times higher than those if purchased outside of the country. CONCLU-SIONS: The results of this study substantiate the common belief that there is extreme variation and inflation of drug prices in the Philippines. Other related studies have also shown that these considerable discrepancies cannot be attributed wholly to the more common reasons for price variance such as transportation, purchasing power, market fluctuations, etc. This study's findings also give PHIC further license to develop an index of drug reference prices that will serve as a basis for drug reimbursement in the hope of encouraging the more rational and fair pricing of drugs.
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THE VALUE OF BOARD OF PHARMACEUTICAL SPECIALTY CERTIFICATION: RESOURCE USE AND DECISION-MAKING
Ryan M, Romanelli F, Smith KM, Cain JJ University of Kentucky, Lexington, KY, USA
OBJECTIVES:
To determine financial and professional benefits to examinees for Board of Pharmceutical Specialties (BPS) certification. METHODS: An anonymous web-based survey was developed and pre-tested. The survey was sent to all 84 US colleges of pharmacy. Demographics captured included college size, mean yearly research dollars, faculty size, and enrollment. Information regarding numbers of BPS-certified faculty, the extent to which BPS certification was considered in recruitment, and compensation/incentives provided to faculty for certification was obtained. RESULTS: Thirty-five surveys were returned. Deans completed surveys (54%) and division/ department chairs (43%). Mean number of full-time faculty members/institution was 24 (range 9-60). Mean number of full-time board certified faculty members was 7 (20%), with a range of 0-25. No institution required board certification for new faculty members; 8 (23%) anticipated such a requirement for currently non-certified faculty. Costs to examinees are estimated with minimum and maximum expenses varied for test cases. The survey revealed that expenses reimbursed varied considerably, with 34% reimbursing no expenses, 34% reimbursing a preparatory course and examination fee, 23% reimbursing the examination fee only if the examinee is successful, and 11% reimbursing travel expenses. The amount of reimbursement was tabulated. While 66% of respondents stated they encouraged faculty to seek board certification, fewer had faculty incentives. Only 17% provided salary increases and 6% granted promotion to recognize faculty members. Most institutions considered board certification in promotion and tenure (66%) and provided public recognition of successful examinees (51%). Potential values were attached to the promotion and tenure and public recognition variables based on literature values. CONCLUSIONS: BPS certification is not required at this time for any US college of pharmacy. Therefore, faculty members should consider the costs and benefits associated with pursuing such certification. This information may assist faculty members in resource use and decisionmaking with regard to BPS certification.
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MECHANISMS AND OUTCOMES OF UTILIZATION REVIEW CONDUCTED AMONG PHIC-ACCREDITED HEALTH CARE FACILITIES IN THE PHILIPPINES
Valera MR, Soria FZ, Lavina SMS, Laureta-Barbaza JA, Banting MPC, Calces AAC Philippine Health Insurance Corporation, Pasig, Rizal, Philippines
OBJECTIVE: To describe the mechanisms and outcomes of utilization review conducted by Philippine
Health Insurance Corporation on its health providers. METHODS: Utilization review conducted among PHICaccredited health providers consisted of three components. First part involved retrospective review of claims database wherein the initial focus was on hospital outliers (i.e. small percentage of hospitals that have utilization rates significantly higher than their counterparts) and identification of utilization patterns of care and medical services rendered. Second portion was an external review process wherein a group of practicing physicians functioned as peer review committee evaluating whether the care provided was medically appropriate and necessary. Third part included assessment of the rationality of drug use in selected regions of the Philippines. RESULTS: Based on bed occupancy rate and number of claims filed, 126 PHIC-accredited facilities nationwide were identified as outliers. Majority of the hospitals identified with extreme utilization rates were privately owned and were categorized as primary hospitals. Forty-eight percent (61/126) of the hospitals identified as outliers had extremely disproportionate reimbursements for acute bronchitis. Among the varied clinical cases deliberated on by the peer review committee, management in 33% was found to be inappropriate and unnecessary. Based on review of prescriptions, the average number of prescriptions per patient encounter in selected hospitals was 3 drugs (SD ± 3). Ninety percent of these prescriptions were written in generics. 31% of these prescriptions were for antibiotics. One drug prescription based on existing data costs about P321.00 (Equivalent to $ 6 per prescription). CONCLUSION: Unnecessary, inappropriate, or excessive use of medical services was identified through the different mechanisms of utilization review. The data gathered paved the way to a feedback process for health providers that can possibly translate into reduced inappropriate variations in the use of medical health care services and then perhaps cost-savings.
PHP26
INTENSIVIST PRACTICE CHANGE IN GLUCOSE CONTROL FOR CRITICALLY ILL PATIENTS
Conner T 1 , Drosu D 1 , Krstic B 1 , Rankin S 1 , Newby C 1 , Rascati KL 2 , Flesner K 1 , Weingarten J 1 1 Brackenridge Hospital, Austin, TX, USA; 2 University of Texas at Austin, Austin, TX, USA There is increasing evidence that tighter control of glucose levels in critically ill patients improves patient outcomes. OBJECTIVES: To determine if education and implementation of a continuous insulin infusion protocol during 2002 improved glucose control in the intensive care setting. METHODS: A retrospective chart review was conducted on ICU patients during a four-month period in one of three consecutive years. Patients were included if they were in the ICU for a minimum of three days, were ventilated, received care from an intensivist, and had a medical DRG at discharge. Additional information was gathered from electronic charge data. Alpha for all analyses was set at 0. 
THE ASSOCIATION OF RECOMMENDED SURGICAL SITE INFECTION GUIDELINES AND OTHER FACTORS WITH HOSPITAL LENGTH OF STAY (LOS) IN PATIENTS UNDERGOING DIFFERENT CLEAN OR CLEAN-CONTAMINATED PROCEDURES
Bonnet PO 1 , Barlev A 1 , Johnson KA 1 , Hopefl A 2 1 University of Southern California, Los Angeles, CA, USA; 2 AmeriNet, St. Louis, MO, USA
OBJECTIVES:
To determine what factors can help to predict if patients undergoing 13 different clean or cleancontaminated procedures will get the recommended antimicrobial prophylaxis and to investigate the association of compliance to published surgical site infection guidelines and other factors with hospital length of stay (LOS). METHODS: Data included 2047 patients undergoing cardiac, gynecologic, gastrointestinal, and arthroplasty procedures, from 47 hospitals during a 3-month period. Data included patient demographic,
